Atopic Dermatitis – Home Therapy with Medicinal Plants

Atopic dermatitis represents one of the most prevalent allergic skin disorders, disproportionately affecting infants and young children during early developmental stages. The condition is clinically defined by persistent, often debilitating pruritus that typically intensifies during evening and nocturnal hours. The distribution of cutaneous lesions exhibits age-related variability: in pediatric patients, eczematous changes predominantly involve the facial region, extensor surfaces of the elbows, and knees, whereas adults more commonly present with flexural involvement at the antecubital and popliteal fossae, as well as the face and neck.

Associated symptomatology may include hypersensitivity reactions to specific dietary antigens, elevated serum immunoglobulin E levels, facial pallor or erythema, marked xerosis of the epidermis, the presence of fine white scaling, recurrent conjunctivitis, and accentuated palmar dermatoglyphics—termed hyperlinearity. Epidemiological evidence indicates that approximately 60% of diagnoses occur within the first year of life, highlighting the disorder’s early-onset nature and its substantial impact on pediatric dermatological practice.

Given that atopic dermatitis is inherently a chronic and relapsing condition, therapeutic interventions are primarily designed to mitigate symptomatic manifestations rather than achieve a definitive cure. The cornerstone of management lies in meticulous skincare practices coupled with the avoidance of environmental and behavioral triggers that may precipitate or exacerbate dermatological lesions. Of paramount importance is the consistent application of high-potency emollients—specifically, thick creams or ointments—across the entire cutaneous surface at least twice daily, with an estimated weekly consumption of no less than 250 grams. For individuals presenting with severe xerosis, urea-based formulations (ranging from 5% to 40% concentration) or 12% lactic acid may offer additional benefit, though transient stinging sensations should be anticipated. A multitude of extrinsic factors can aggravate atopic symptoms; thus, practices that desiccate the skin—such as prolonged immersion in hot water or vigorous toweling—must be scrupulously avoided. Immediately following water exposure, emollients should be reapplied, while soap use should be restricted solely to intertriginous zones (axillae, inguinal folds, and feet). Appropriate clothing selection is equally critical: loose-fitting, breathable garments composed of hypoallergenic natural fibers (e.g., cotton) are strongly recommended. Newly acquired apparel should undergo laundering prior to initial wear to eliminate residual chemical irritants. Environmental modifications are likewise essential; abrupt thermal fluctuations, excessive humidity, or arid atmospheric conditions should be minimized. Furthermore, stress-reduction techniques (e.g., mindfulness or relaxation exercises) and the exclusion of suspected dietary triggers may yield adjunctive therapeutic benefits.

Within the comprehensive management of atopic dermatitis (AD), botanical preparations rich in biologically active fatty acids—particularly γ-linolenic acid (GLA)—play a pivotal role in symptom alleviation. Among topical applications, borage seed oil (*Borago officinalis*) and evening primrose oil (*Oenothera biennis*) are distinguished for their hydrating and anti-inflammatory properties, which may facilitate epidermal repair. In the context of oral supplementation, clinical trials are evaluating the efficacy of evening primrose extracts in age-stratified dosages: pediatric patients (aged 1–12 years) are recommended 160–320 milligrams per day, whereas adults receive 320–480 milligrams. The absence of improvement following a three-month therapeutic trial serves as a criterion for deeming the intervention ineffective, necessitating a revision of the treatment protocol. Complementary local formulations may incorporate milk thistle (*Silybum marianum*) or Baikal skullcap root (*Scutellaria baicalensis*) extracts, whose antioxidant and immunomodulatory effects could augment primary therapy. It is critical to emphasize that AD is a chronic condition with an etiology that remains incompletely understood, and current treatment modalities are primarily symptomatic. Nonetheless, the prognosis is favorable: in the majority of affected individuals, symptom severity diminishes with age, often resolving entirely or transitioning into a milder form, thereby enabling management through consistent skincare regimens and appropriately selected dermocosmetic products.